AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
EVMN vs EVFM Fundamental Comparison
| Metric | EVMN | EVFM |
|---|---|---|
| Revenue | $13.0M | $20.2M |
| Net Income | $-68.9M | $391,000.0 |
| Net Margin | -529.8% | 1.9% |
| ROE | -33.5% | N/A |
| ROA | -30.6% | 1.9% |
| Current Ratio | 8.57x | 0.18x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-11.22 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EVMN vs EVFM: Frequently Asked Questions
Is EVMN or EVFM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. EVMN is rated STRONG SELL (92% confidence) while EVFM is rated STRONG SELL (92% confidence). This is not investment advice.
How does EVMN compare to EVFM fundamentally?
Evommune, Inc. has ROE of -33.5% vs Evofem Biosciences, Inc.'s N/A. Net margins are -529.8% vs 1.9% respectively.
Which stock pays higher dividends, EVMN or EVFM?
EVMN has a dividend yield of N/A or no dividend while EVFM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EVMN or EVFM for long term?
For long-term investing, consider that EVMN has STRONG SELL rating with 92% confidence, while EVFM has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EVMN vs EVFM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EVMN vs EVFM, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.